http://cancerconference.afiuk.org/

Cancer Innovation & Future Leaders Conference UK, Lewis Gardens, Colchester (2026)

04/10/2026

System leadership matters in the fight for more equitable cancer care.

We are delighted to welcome contributions from NHS Norfolk and Suffolk and NHS Essex at the Cancer Innovation and Future Leaders Conference 2026.

Their involvement brings an important system perspective to a programme centered on a shared challenge: ensuring that progress in cancer prevention, early diagnosis, treatment and support reaches every community—not only those best placed to access it.

Cancer inequalities are shaped by far more than clinical care alone. Deprivation, geography, culture, language, trust, health literacy and the ability to navigate services can all influence when someone seeks help, receives a diagnosis and accesses support.

At the Conference, we will explore how data, innovation, local leadership and genuine partnership with communities can help bring services closer to the people who need them most.

From the opening keynote, The Future of Equitable Cancer Care: Bridging Innovation and Community in East Anglia,” to discussions on early diagnosis, health literacy, trust, technology and community co-design, the programme creates space for practical, cross-sector learning.

We look forward to hearing how local NHS leadership and partnership working can help turn ambition into better, fairer cancer outcomes.

Cancer Innovation and Future Leaders Conference 2026
📍 Firstsite, Colchester
📅 Thursday 22 October 2026

Register and view the programme: cancerconference.afiuk.org

02/10/2026

The Cancer Innovation and Future Leaders Conference 2026 brings together healthcare professionals, researchers, innovators, charities, community leaders, students and people with lived experience for two days of ideas, practical learning and meaningful collaboration.

Cancer care is changing and communities are already helping to shape its future through research participation, innovation, lived experience, local leadership, research participation and practical support for people affected by cancer.

Taking place on **22–23 October 2026 at Firstsite, Colchester**, the conference will explore:

• Equitable cancer care, trust and community engagement
• Real-world evidence, data and innovation
• Migration, access and health inequalities
• Legal frameworks for new health technologies
• Science communication and future leadership
• Community co-design through *Map the Support, Map the Gaps*—helping shape a trusted local cancer-support resource

With contributions from leaders across the NHS, research, community and innovation sectors, this is a space to learn, connect and contribute to better cancer outcomes.

Join the conversation. Help shape what comes next.

Register now and view the full programme: https://cancerconference.afiuk.org/

21/09/2026

📣 Workshop Announcement
Community Co‑Design Cancer Workshop: Map the Gap, Map the Support

For many people affected by cancer, the support landscape can feel fragmented and difficult to navigate. Services may exist, but they are often hard to find:
• information is scattered across multiple websites
• referral pathways are unclear
• smaller, trusted community groups are frequently invisible in conventional directories

These challenges are even greater for individuals facing language, transport, financial, cultural, or digital barriers.

This community co‑design workshop will explore how to build a **community‑led digital resource** that makes it easier for people living with cancer — along with their carers, families, and the community workers who support them — to find relevant, local help quickly and confidently.

Workshop Aim
To identify how we can make the local support ecosystem easier to navigate while giving community organisations greater visibility and a practical tool for connecting people to the right support at the right time.

Why Community Partnership Matters
Community groups, charities, carers’ organisations, faith networks and local leaders understand the trusted routes through which people seek help. Their insight is essential to ensuring that any resource map is inclusive, culturally relevant, and kept up to date.

Launching at the Cancer Innovation & Future Leaders Conference 2026
The project begins with our co‑design session, “Map the Support, Map the Gaps.”
Participants will work together to identify the support people need, map existing trusted services, define what makes information accessible, and agree on the first pilot area and priorities.

Our Shared Commitment
Cancer Support Near You* will be community‑led, inclusive, accessible, non‑clinical, transparent, and collaboratively maintained. Its success will be measured by one simple outcome: whether a person or community worker can find and share appropriate local support quickly, confidently, and with dignity.

Join us in shaping a future where cancer support is easier to find — and where no community is left off the map.

📅 Date: Friday, 23 October 2026
⏰ Time: 11:00 AM – 1:00 PM

---

28/08/2026

WORKSHOP ANNOUNCEMENT | CANCER INNOVATION & FUTURE LEADERS CONFERENCE 2026

We are pleased to welcome Ruth Nanjala, PhD, as a workshop facilitator at the Cancer Innovation & Future Leaders Conference 2026, taking place at Firstsite, Colchester.

Shape Understanding: The Power of Science Communication

Great research can generate evidence. Great science communication can turn that evidence into understanding, engagement and action. Whether you are presenting research, competing for funding, communicating with patients and communities, influencing policy, or pitching an innovation to healthcare and industry leaders, the ability to communicate complex science clearly is an essential skill.

That’s why we’ve partnered with Ruth Nanjala, PhD, and the team at My Science Journey to bring an interactive Science Communication Workshop directly to the conference.

What will you gain from the session?

- Make complex science accessible: Learn how to explain genetics, algorithms, clinical pathways and complex research clearly and concisely without losing scientific integrity.

- Translate research for different audiences: Develop techniques for communicating translational oncology and scientific evidence beyond specialist audiences, including patients, communities, decision-makers and the wider public.

- Communicate with cultural awareness: Explore how language, context and audience understanding can shape whether scientific information is trusted, understood and acted upon.

- Strengthen your scientific storytelling: Move beyond presenting data to communicating why your research matters, what problem it addresses and what impact it could have.

- Sharpen your conference presentation: For abstract presenters, this is an opportunity to strengthen your delivery before presenting your work to an evaluation panel that includes leaders from healthcare, academia and industry.

The ability to conduct excellent research matters. The ability to make people understand why it matters can determine how far that research travels. This interactive workshop is integrated into the conference programme and will be available to accepted presenters and conference attendees.

Whether you are an early-career researcher, clinician, data scientist, innovator or future healthcare leader, come prepared to communicate your science with clarity, confidence and impact.

See the replies for abstract guidelines and the submission link.

28/08/2026

SPEAKER ANNOUNCEMENT | CANCER INNOVATION & FUTURE LEADERS CONFERENCE 2026

We are pleased to welcome Elizabeth Patterson as a speaker at the Cancer Innovation & Future Leaders Conference 2026, taking place at Firstsite, Colchester, in October 2026.

When Innovation Moves Faster Than the Rulebook...

Some of the most exciting developments in cancer care are emerging at the intersection of precision oncology, artificial intelligence, genomic medicine and digital health.

But developing breakthrough technology is only part of the journey. For innovations such as AI-enabled diagnostics, Software as a Medical Device (SaMD), machine-learning clinical tools and federated genomic platforms to move safely from research into real-world healthcare, they need robust legal, regulatory and governance frameworks around them.

The challenge is therefore not simply “How do we regulate innovation?” It is also: “How do we build legal frameworks that enable responsible innovation to reach patients safely, efficiently and equitably?”

This is why legal and regulatory strategy is an important pillar of the Cancer Innovation & Future Leaders Conference 2026.
Elizabeth Patterson will bring a legal perspective to this critical intersection between innovation, regulation, data governance and healthcare implementation.

Key themes include:

- Enabling Safe Market Access: Navigating evolving regulatory pathways for AI-enabled diagnostics and digital medical technologies while maintaining rigorous standards of clinical safety and evidence.

- Making Responsible Data Collaboration Possible: Exploring governance, intellectual property and data-sharing frameworks that can enable multi-centre research and federated approaches while protecting patient data and meeting GDPR requirements.

- Understanding Liability in AI-Supported Care: Addressing accountability and liability when clinicians and healthcare organisations increasingly use algorithmic decision-support technologies.

- Protecting Intellectual Property While Supporting Access: Balancing the IP protection needed to incentivise research and investment with the wider goal of making valuable innovations accessible to health systems and patients.

- Supporting Health-Tech Translation and Spinouts: Helping researchers, universities and entrepreneurs understand the legal and commercial pathways involved in translating scientific discoveries into viable healthcare innovations.

The future of cancer innovation will require more than scientific breakthroughs, sophisticated algorithms and investment. It will also require legal frameworks capable of creating trust, accountability and a safe pathway from discovery to adoption.

Because the goal is not simply to innovate faster. It is to ensure that valuable innovation can reach patients safely, responsibly and equitably.

Secure your delegate pass and explore the full conference programme via the link in the comments below.

27/08/2026

KEYNOTE SPEAKER ANNOUNCEMENT

We are proud to welcome Dr Ed Garratt OBE, Chief Executive of the NHS Norfolk and Suffolk Integrated Care Board (ICB), as a confirmed Keynote Speaker at the Cancer Innovation & Future Leaders Conference 2026, taking place at Firstsite, Colchester.

Equitable Cancer Care: Bridging Innovation and Community in East Anglia.

The future of cancer care will not be shaped by innovation alone. It will depend on our ability to ensure that innovation reaches the communities that need it most.

As health systems increasingly focus on prevention, earlier diagnosis, digital transformation and shifting more care from hospitals into communities, a critical question emerges:

How do we translate innovation into better and more equitable cancer outcomes at population level?

Leading an integrated health system serving approximately **1.7 million people, Dr Garratt brings a vital system-level perspective to this conversation.

His keynote will explore the intersection between cancer innovation, population health and community-based care, including:

- From Hospital to Community: How health systems can move prevention, early detection and appropriate elements of cancer care closer to where people live.

- Innovation for Prevention & Earlier Diagnosis: Harnessing digital tools, data and new approaches to identify risk, improve screening engagement and support earlier intervention.

- Tackling Health Inequalities: Ensuring that geography, deprivation and other barriers do not determine who benefits from advances in cancer care.

- Connecting Innovation with Integrated Care: Exploring the role of ICBs in bringing together NHS organisations, local government, communities and innovators around shared population-health priorities.

- Building the Future of Cancer Care in East Anglia: What system leadership, collaboration and innovation can achieve when focused on better outcomes for communities.

The challenge is not simply to create the next generation of cancer innovation. It is to build health systems capable of translating that innovation into earlier diagnosis, more equitable access and better outcomes for patients.

Join healthcare leaders, clinicians, researchers, data scientists, innovators and emerging leaders as we explore how to turn innovation into real-world impact.

👇 **Secure your delegate registration and explore the full conference programme via the link in the comments below.**

27/08/2026

We are pleased to welcome Dr Matthew Sweeting as a speaker at the Cancer Innovation & Future Leaders Conference 2026, taking place at Firstsite, Colchester, in October 2026.

Clinical trials remain fundamental to establishing the safety and efficacy of new cancer interventions. But tightly controlled trial populations do not always reflect the complexity and diversity of patients encountered in everyday clinical practice.

This is where Real-World Data (RWD) and Real-World Evidence (RWE) can play an increasingly important role.

By connecting clinical research, data science and real-world practice, we can better understand how innovations perform across diverse patient populations and create a continuous learning cycle between research, evidence and patient care.

Dr Sweeting will bring his expertise to this important conversation, exploring how data and evidence can help bridge the gap between research and real-world healthcare delivery.

Key themes include:

- Bridging the efficacy effectiveness gap: Using real-world population data to understand whether findings from studies translate effectively across broader and more diverse patient groups.

- Accelerating translation: Connecting clinical, genomic and longitudinal health data to strengthen evidence generation, refine patient selection and support the development of new approaches to cancer care.

- Building learning health systems: Creating feedback loops where insights from routine care inform future research, biomarker development, treatment strategies and clinical decision-making.

- Demonstrating value to health systems: Generating the evidence healthcare leaders, commissioners and NHS Integrated Care Boards (ICBs) need to assess which innovations deliver meaningful patient and system-level value.

At the Cancer Innovation & Future Leaders Conference 2026, we are bringing together academia, innovators and community leaders and health system leaders to explore how this integration can move from concept to practice.

Because the future of cancer innovation is not simply about generating more data but turning evidence into better decisions, better systems and better outcomes for patients.

👇 **Secure your delegate registration and explore the full conference agenda via the link in the comments below.**

26/08/2026

We are pleased to welcome Professor Renee Luthra, Deputy Director of the ESRC Research Centre on Micro-Social Change, as a speaker at the Cancer Innovation & Future Leaders Conference 2026, taking place at Firstsite, Colchester.

Healthcare disparities experienced by immigrant families are not simply a matter of clinical availability. They can also be shaped by structural barriers, communication challenges, difficulties navigating healthcare systems, and institutional trust.

When migrant communities encounter barriers to accessing and navigating primary care, the consequences can extend across the cancer pathway from lower screening uptake and delayed presentation to later diagnosis and poorer outcomes. Closing these gaps requires moving beyond assumptions to understand the micro-social dynamics that shape how individuals and families engage with health systems.

Professor Luthra will bring data-backed insights to this important discussion in her session:

Migration, Trust and Access: Understanding How Immigrant Families Engage with Health Systems.

Key focus areas include:

- Understanding pathways to late diagnosis: Identifying the social, informational and administrative barriers that can delay engagement with NHS cancer screening, primary care and referral pathways.

- Understanding institutional trust: Exploring how historical experiences, language, migration background and socio-cultural factors can shape engagement with healthcare, participation in research and treatment pathways.

- Translating micro-social data into policy: Using social science evidence to inform how Integrated Care Boards (ICBs) and other health system leaders can develop more culturally responsive, accessible and community-anchored models of care.

To build a more equitable future in oncology, health tech innovators, clinical leaders and policymakers must understand the human realities behind the data and how those realities shape access, trust and engagement with healthcare.

👇 **Secure your delegate registration and view the full conference agenda via the link in the comments below.**

26/08/2026

We are proud to welcome Dr. Yemisi Sloanne of Anglia Ruskin University as a speaker at the Cancer Innovation and Future Leaders Conference 2026, taking place at Firstsite, Colchester.

Equity, Trust and Cultural Intelligence: Engaging Communities in the Future of Health Innovation

An AI diagnostic algorithm, liquid biopsy or breakthrough treatment can only achieve its full potential if the communities it is designed to serve trust and engage with the healthcare system delivering it.

As oncology becomes increasingly driven by data, AI and precision medicine, innovation cannot be measured by scientific advancement alone. Its real impact depends on whether people participate in screening, present early, are represented in research, navigate care successfully and trust the systems making decisions about their health.

That makes health equity, cultural intelligence and community trust fundamental components of cancer innovation.

True innovation means designing with communities and not just simply designing solutions for them.

In this important session, Dr. Sloanne will explore how healthcare leaders, researchers and innovators can bridge the gap between technological progress and real-world impact.

Key themes will include:

- Overcoming implementation barriers: How Cultural Intelligence (CQ) can help address mistrust and strengthen engagement with screening and early diagnosis.

- Data & algorithmic equity: Building more representative research and clinical trials while reducing bias in data-driven diagnostic models.

- Co-design over paternalism: Developing community-anchored approaches that strengthen patient navigation, engagement and treatment adherence.

- Value for health systems and ICBs: How stronger community trust and more equitable pathways can support earlier intervention and help reduce the burden of late-stage cancer.

The future of cancer innovation is not only about what technology can do. It is also about who benefits, who participates and who trusts it.

Secure your delegate registration via the link in the comments below.

19/08/2026

Bringing Young Scientists, Innovators and Community Together.

Cancer Innovation & Future Leaders Conference
Dates: 21-23 October 2026
Venue: Firstsite Gallery, Colchester

Registration is Ongoing!

Cancer Innovation & Future Leaders Conference UK

04/10/2026

02/10/2026

21/09/2026

28/08/2026

28/08/2026

27/08/2026

27/08/2026

26/08/2026

26/08/2026

19/08/2026

Address

Website

Alerts

Contact The School

Shortcuts

Share

Category

Listing takedown request